OverviewSuggest Edit

    Cantargia is a biotechnology company that specializes in the development of pharmaceuticals for various types of cancer, autoimmune and inflammatory diseases. It develops CAN04, an antibody against IL1RAP to recognize cancer cells and stimulate the natural immune system to destroy such cells, as well as block the tumor inflammation.

    HQLund, SE


    Cantargia is headquartered in
    Lund, Sweden

    Location Map

    Latest Updates

    Employees (est.) (Feb 2020)8(-42%)
    Cybersecurity ratingAMore

    Key People/Management at Cantargia

    Karin Leandersson

    Karin Leandersson

    Göran Forsberg

    Göran Forsberg

    Thoas Fioretos

    Thoas Fioretos

    Founder and Scientific Advisor, Director
    Bengt Jöndell

    Bengt Jöndell

    Claus Asbjørn Andersson

    Claus Asbjørn Andersson

    Liselotte Larsson

    Liselotte Larsson

    VP Operations
    Show more

    Cantargia Office Locations

    Cantargia has an office in Lund
    Lund, SE (HQ)
    Scheelevägen 27
    Show all (1)

    Cantargia Financials and Metrics

    Cantargia Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    Cantargia Online and Social Media Presence

    Embed Graph

    Cantargia Frequently Asked Questions

    • When was Cantargia founded?

      Cantargia was founded in 2010.

    • Who are Cantargia key executives?

      Cantargia's key executives are Karin Leandersson, Göran Forsberg and Thoas Fioretos.

    • How many employees does Cantargia have?

      Cantargia has 8 employees.

    • Who are Cantargia competitors?

      Competitors of Cantargia include Cybrexa Therapeutics, Sonnet BioTherapeutics and Immutep.

    • Where is Cantargia headquarters?

      Cantargia headquarters is located at Scheelevägen 27, Lund.

    • Where are Cantargia offices?

      Cantargia has an office in Lund.

    • How many offices does Cantargia have?

      Cantargia has 1 office.